Caroline Behler, M.D., MS
Investigator
Caroline Marie Behler, MD, MS is a hematology-oncology specialist and Partner at Pacific Hematology Oncology Associates at California Pacific Medical Center in San Francisco. She also serves as Program Director of the Hematology/Oncology Fellowship and as an Assistant Adjunct Clinical Professor of Medicine at Dartmouth University.
Dr. Behler completed her hematology/oncology fellowship and internal medicine residency at the University of California, San Francisco, after earning her medical degree with honors from the University of Washington School of Medicine.
Prior to her current roles, she held faculty positions at UCSF and served as Chief of Malignant Hematology at the San Francisco Veterans Affairs Medical Center.
Dr. Behler is board-certified in hematology and oncology and is actively involved in clinical research as a principal investigator in hematology/oncology clinical trials. She has contributed to numerous peer-reviewed publications and is a member of leading professional organizations, including the American Society of Hematology and the American Society of Clinical Oncology.
Clinical trials
- Clinical trial
Neoadjuvant Lymphoma DLBCL waveLINE-010
A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010) MK-2140-010
Status: Open to Enrollment